Balyasny Asset Management
KRRO icon

Balyasny Asset Management’s Korro Bio KRRO Stock Holding History

Balyasny Asset Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.8M Buy
+1,040,054
New +$11.4M 0.02% 963
2025
Q1 		– Sell
-5,778
Closed -$220K – 3058
2024
Q4 		$220K Buy
+5,778
New +$297K ﹤0.01% 2503
2024
Q2 		– Sell
-3,773
Closed -$340K – 2861
2024
Q1 		$340K Buy
+3,773
New +$206K ﹤0.01% 2212
2022
Q4 		– Sell
-235
Closed -$21K – 3013
2022
Q3 		$21K Buy
+235
New +$23.9K ﹤0.01% 2579

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Balyasny Asset Management's KRRO Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in Korro Bio (KRRO) in Q1 2026: 1,040,054 shares worth $11.8M. The stake represents 0.02% of the portfolio and ranks #963 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in KRRO as recently as Q4 2024.

Balyasny Asset Management first reported a position in KRRO in Q3 2022 and has held it in 4 quarters since. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Balyasny Asset Management held 1,040,054 shares of Korro Bio worth $11.8M as of Q1 2026.
  • Korro Bio was a new Balyasny Asset Management position in Q1 2026.
  • Korro Bio made up 0.02% of Balyasny Asset Management's portfolio in Q1 2026, its #963 holding.
  • Balyasny Asset Management first reported a position in Korro Bio in Q3 2022 and has held it in 4 quarters since.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.